SLC6A3 and Parkinson disease: Previous neurotransmitter studies have suggested that higher anxiety levels in PD are associated with decreased dopamine transporter (DAT) binding in the bilateral caudate, the left putamen, and reduced noradrenaline transporter (NAT) in the left caudate [30,31].